提质增效重回报
Search documents
宏力达(688330.SH):预计2025年净利润同比增加185.09%左右
Ge Long Hui A P P· 2026-01-29 09:15
2025年度归属于母公司所有者的净利润较上年同比增长主要是由于公司对外股权投资产生的公允价值变 动损益较上年同期大幅增长。2025年受行业市场竞争加剧影响,预计公司营业收入较上年同期下降。公 司积极落实"提质增效重回报"行动方案,加强应收账款回款管理,加快业务回款进度,应收账款规模下 降幅度较大,前期计提的坏账准备在本期冲回。公司2025年度归属于母公司所有者的扣除非经常性损益 的净利润较上年同期有所上升。 格隆汇1月29日丨宏力达(688330.SH)公布,经财务部门初步测算,预计2025年年度实现归属于母公司所 有者的净利润为63,500.00万元左右,同比增加185.09%左右。2025年年度实现归属于母公司所有者的扣 除非经常性损益的净利润为18,000.00万元左右,同比增加4.94%左右。 ...
中原高速:关于公司“提质增效重回报”行动方案的公告
Zheng Quan Ri Bao· 2026-01-28 13:40
证券日报网讯 1月28日,中原高速发布公告称,公司发布"提质增效重回报"行动方案,提出五方面举 措:一、聚焦做强主业,提升经营效率和盈利能力;二、完善公司治理,强化合规经营;三、加强投关 建设,增强股东回报;四、深化科技创新,激发发展新动能;五、强化"关键少数"责任,护航稳健发 展。 (文章来源:证券日报) ...
亏损降幅60%!华大智造2025年业绩预告
思宇MedTech· 2026-01-28 02:40
Core Viewpoint - The company, BGI Genomics (stock code: 688114.SH), has released its earnings forecast for 2025, indicating a significant reduction in losses compared to the previous year, driven by operational improvements and favorable currency exchange impacts [2][4]. Financial Performance - The company expects a net profit attributable to shareholders of between -221 million to -273 million yuan for 2025, a notable improvement from a loss of 601 million yuan in the previous year, representing a year-on-year reduction of approximately 54.56% to 63.22% [4]. - After excluding non-recurring gains and losses, the anticipated net profit is projected to be between -322 million to -397 million yuan, compared to a loss of 653 million yuan last year, indicating a year-on-year improvement of about 39.18% to 50.67% [4]. Reasons for Performance Changes - The company has implemented measures focused on "quality improvement, efficiency enhancement, and return on investment," leading to a decrease in overall costs compared to the previous year [5]. - Currency exchange gains from holding foreign currency monetary items have increased due to fluctuations in the US dollar and euro [5]. - The company has reversed tax provisions related to previous years' uncertain tax disputes, resulting in a reduction in income tax expenses [5]. Company Overview - BGI Genomics is a domestic manufacturer focused on core tools and high-end equipment in life sciences, primarily engaged in gene sequencing and related laboratory automation equipment [6]. - The company emphasizes independent research and development, providing foundational technical equipment and systematic solutions for research institutions, clinical testing laboratories, and industrial clients [6]. Business Segments Gene Sequencing Business - The gene sequencing business is the core segment, continuously upgrading products and reagents to enhance sequencing efficiency, coverage, and application adaptability [7]. - In 2024, the company plans to launch the next-generation sequencing reagent StandardMPS 2.0, along with upgrades to several core sequencing platforms, enhancing their applicability across various research and clinical needs [9]. Laboratory Automation Business - The company is advancing towards systematic and intelligent upgrades in laboratory automation, focusing on key processes such as sample handling, experimental execution, and data analysis [10]. - New products like αLabStudio, αLabRobot, and αCube are being introduced to improve sample management efficiency and experimental stability [12]. New Business Segment - The new business segment focuses on multi-omics tools, ultrasound imaging, and intelligent robotics, aiming to meet cutting-edge research and clinical transformation needs [13][15]. - The company is expanding its capabilities in cell omics, spatiotemporal omics, and proteomics, enhancing high-throughput data collection and analysis [15][16].
华发股份:公司不存在未披露的重大事项
Zheng Quan Ri Bao Wang· 2026-01-27 13:52
证券日报网讯1月27日,华发股份(600325)在互动平台回答投资者提问时表示,公司不存在未披露的 重大事项。公司股价走势受经济环境、房地产行业、市场偏好等多种因素影响,当前股价未能充分反映 公司内在价值。公司于2024年12月24日发布了《珠海华发实业股份有限公司"提质增效重回报"行动方 案》,旨在以提升公司高质量发展为基础,切实履行上市公司的责任和义务,保障投资者权益,共同促 进资本市场平稳健康发展。面对行业调整的大背景,公司在提升基本面的同时,也努力通过开展中期分 红、回购股份等措施稳定市场信心,维护公司价值和股东利益。 ...
深圳华大智造科技股份有限公司2025年年度业绩预告
Shang Hai Zheng Quan Bao· 2026-01-25 19:13
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 重点内容提示 ●公司经初步测算,深圳华大智造科技股份有限公司(以下简称"公司")预计2025年年度实现归属于母 公司所有者的净利润与上年同期(法定披露数据)相比,实现归属于母公司所有者的净利润-27,300.00 万元到-22,100.00万元,与上年同期相比,亏损将减少32,782.70万元到亏损减少37,982.70万元,同比亏 损减少54.56%到亏损减少63.22%。 ●公司预计2025年年度实现归属于母公司所有者的扣除非经常性损益的净利润 -39,700.00万元 到-32,200.00万元,与上年同期相比,亏损将减少25,570.68万元到亏损减少33,070.68万元,同比亏损减 少39.18%到亏损减少50.67%。 证券代码:688114 证券简称:华大智造 公告编号:2026-001 深圳华大智造科技股份有限公司 2025年年度业绩预告 (二)业绩预告情况 1、经公司初步测算,预计2025年年度实现归属于母公司所有者的净利润与上年同期(法定披露数据) 相比,实 ...
国芯科技:公司正持续推进“提质增效重回报”专项行动,不断强化核心竞争力与市场地位
Zheng Quan Ri Bao Wang· 2026-01-23 13:46
证券日报网讯1月23日,国芯科技在互动平台回答投资者提问时表示,公司正持续推进"提质增效重回 报"专项行动,不断强化核心竞争力与市场地位。管理层对公司未来发展抱有坚定信心,将继续通过技 术创新与市场突破推动公司价值持续成长,努力为全体股东创造长期、稳健的回报。 ...
利扬芯片:2025年度,公司继续深入开展“提质增效重回报”行动
Zheng Quan Ri Bao Wang· 2026-01-23 11:12
证券日报网讯1月23日,利扬芯片在互动平台回答投资者提问时表示,2025年度,公司继续深入开展"提 质增效重回报"行动,通过如下方式实施:公司聚焦集成电路测试主业,打造"一体两翼"的战略布局; 坚定创新驱动发展方针,赋能竞争"核"动力;优化并提升管理效能。 ...
博睿数据(688229.SH)发预亏,预计2025年度归母净亏损9000万元至1亿元
智通财经网· 2026-01-21 09:00
报告期内,公司营业收入较上年同期相比有所下降,公司营业收入较上年同期相比变动原因主要为: 2025年度公司主动式产品收入较上年同期降幅较大,虽然被动式产品收入较上年同期有一定增长,但不 足以弥补主动式产品收入的降幅,被动式产品收入的增长主要受益于BonreeONE产品的贡献。同时,经 初步测算,公司对联营企业北京智维盈讯网络科技有限公司计提长期股权投资减值准备;依据《企业会 计准则18号-所得税》终止确认部分递延所得税资产。此外,公司积极贯彻落实"提质增效重回报"行动 方案,通过实施多项降本增效措施,实现了管理费用、销售费用及研发费用同比下降。上述因素综合影 响,使本报告期内公司归属于母公司所有者的净利润同比增加1,517.45万元到2,517.45万元。 智通财经APP讯,博睿数据(688229.SH)发布2025年年度业绩预告,预计公司2025年年度实现归属于母 公司所有者的净利润为-9000万元至-1亿元,与上年同期相比,将增加1,517.45万元到2,517.45万元。 ...
江苏共创人造草坪股份有限公司 第三届董事会第十五次会议决议公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2026-01-15 23:48
Group 1 - The company held its 15th meeting of the third board of directors on January 15, 2026, with all 7 directors present, and the meeting was conducted in accordance with relevant regulations [2][4] - The board approved the "Quality Improvement and Efficiency Enhancement Action Plan," which aims to promote high-quality development and enhance investment value [3][6] Group 2 - The company has established itself as a global leader in the artificial turf industry, recognized as one of the preferred suppliers by FIFA, World Rugby, and FIH, and has contributed to the drafting of national standards for artificial turf [6][7] - In the first three quarters of 2025, the company achieved a revenue of 2,474.13 million yuan, a year-on-year increase of 9.52%, and a net profit of 515.21 million yuan, up 30.89%, with cash flow from operating activities increasing by 103.77% [7] Group 3 - The company focuses on innovation and has a robust R&D system, with a team experienced in polymer materials and process design, ensuring its competitive edge in new technologies and products [8] - The R&D team has made significant advancements in high-performance sports turf and sustainable leisure turf products, with sales increasing annually [8] Group 4 - The company is committed to enhancing governance structures and has established a clear framework for decision-making and supervision, ensuring compliance and effective operation [9][10] - The company emphasizes the importance of key personnel in governance and provides training and resources to ensure compliance with regulations [10] Group 5 - The company prioritizes investor returns, implementing a shareholder value return mechanism with cash dividend ratios of no less than 50% for the years 2023 and 2024 [11] - The company aims to maximize social contributions, shareholder interests, and customer value while ensuring a stable profit distribution policy [12] Group 6 - The company is dedicated to improving investor communication and enhancing information disclosure standards, focusing on investor needs and preferences [13] - The company will continue to evaluate the "Quality Improvement and Efficiency Enhancement Action Plan" and fulfill its information disclosure obligations [13]
共创草坪:2025年前三季度营收24.74亿元,增长9.52%
Xin Lang Cai Jing· 2026-01-15 08:09
Core Viewpoint - The company has announced the implementation of the "Quality Improvement and Efficiency Enhancement Return Action Plan" aimed at enhancing operational performance and shareholder returns [1] Financial Performance - For the first three quarters of 2025, the company achieved operating revenue of 2.474 billion yuan, representing a year-on-year increase of 9.52% [1] - The net profit for the same period was 515 million yuan, reflecting a year-on-year growth of 30.89% [1] - The net cash inflow from operating activities reached 542 million yuan, which is a significant year-on-year increase of 103.77% [1] Strategic Initiatives - The company plans to implement a diversification strategy to complete its global industrial chain layout [1] - There will be a focus on innovation-driven initiatives, improvement of governance structures, and strengthening the responsibilities of key personnel [1] Shareholder Returns - The cash dividend payout ratio for 2024 and 2025 will not be less than 50% [1] - The company intends to establish a stable profit distribution plan and enhance communication with investors [1]